Shareholders Shanghai Peixi and its concerted parties have reduced their shareholding ratio to below 5%.

Cormed Diagnostics (688468.SH) announced that on November 29, 2024, the company received a shareholder resolution letter stating that the shareholder Tianjin Ruizhi Real Estate Development Co., Ltd. proposed to transfer 13.78% of its shares in the company to Obei Health Management Group Co., Ltd.

Zhitong FinanceDec 2 17:49

Komei Diagnostic Technology Co., Ltd. Third Quarter Report 2024

SZSIOct 30 00:00 · Announcements

Cormay Diagnostics (688468.SH): Hengqin Junlian Healthcare and LOYAL CLASS plan to shareholding no more than 1.8% of the shares.

GeLongHui announced on September 26th that due to its own capital needs, Hengqin Junlian ZhiKang and LOYAL CLASS plan to reduce their holdings of the company's shares through block trading and bulk trading, with a total reduction of no more than 7,219,940 shares and a total reduction ratio of no more than 1.80% of the company's total shares.

Gelonghui FinanceSep 26 16:54

Express News | Corme Diagnostics: Shareholders plan to reduce their shareholding by no more than 1.80%.

BreakingsSep 26 16:53

Express News | Cormorant diagnosis: Shareholder Shanghai Peixi and its concerted action person HJ CAPITAL's shareholding ratio decreased to 8.77%.

BreakingsSep 3 17:18

Komei Diagnostic Technology Co., Ltd. 2024 Semi-Annual Report

SZSIAug 30 00:00 · Announcements